Notable recent transactions
Download PDFWith 16 offices around the world and deals completed in 32 countries, our team makes us a natural choice for transactions requiring knowledge of, and access to global markets. The healthcare team has completed nearly 100 healthcare related deals - 20 of these deals have completed within the last 18 months. The dedicated team provide in-depth knowledge and industry experience to every project. The business has more than 250 staff across Europe, North America and Asia and running throughout our business is an overriding commitment to exceptional outcomes for our clients.
-
Clearwater Advisers
Adviser to ProClinical on its sale to Independent Clinical Services
View more -
Clearwater Advisers
Adviser to Laboratorios Ordesa on its acquisition of Colnatur
View more -
Clearwater Advisers
Adviser to GIMV, Mérieux Développement on its acquisition of Stiplastics
View more -
Clearwater Advisers
Adviser to LDC on its MBO of Fishawack
View more -
Clearwater Advisers
Adviser to The Creative Engagement Group on its sale to Huntsworth plc
View more -
Clearwater Advisers
Adviser to Chase Search and Selection Limited on receiving investment from Vespa Capital
View more -
Clearwater Advisers
Adviser to Medichem on its acquisition of a majority stake in Ruick Pharma
-
Clearwater Advisers
Adviser to Farmalider SA on its sale of a minority stake to Ascendis Health International Limited
View more -
Clearwater Advisers
Adviser to Peckforton Pharmaceuticals on its sale to Abbey Pharma
View more -
Clearwater Advisers
Adviser to Nutramino on its sale to Glanbia Plc
View more